Interestingly, when we tested the same serum samples on the EUROIMMUN ELISA plate coated with the S protein, we did not observe differences between the COVID-19 convalescent pool and vaccinees who had received two or three doses of the BNT162b RNA vaccine (Fig. 4C). This evidence concerns the gene PROS1 and COVID-19.